Stocks
Adaptive Biotechnologies (ADPT) EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -144.3 | -193.3 | -168.0 | -179.4 | -189.3 | -163.5 | ||
| Changes by years, y/y, % | +104% | +34% | -13% | +7% | +6% | +34.0% | |||
Adaptive Biotechnologies. EBITDA US GAAP, bln rub
Adaptive Biotechnologies. EBITDA US GAAP, changes, %
Adaptive Biotechnologies. EBITDA US GAAP, sum by quarters, bln rub
Adaptive Biotechnologies (ADPT) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -40.2 | -61.1 | -39.3 | -38.5 | -24.6 | -163.5 | |
| Changes by years, y/y, % | +11% | +69% | -19% | 0% | -37% | |||
| Changes by quarters, q/q, % | +3% | +52% | -36% | -2% | -36% | |||
